Welcome to
FarLight
Accelerating commercialization of 222nm FarUVC sterilization
About FarLight
FarLight is a prosocial venture (Beneficial Corporation). Our mission is to end pandemics by preventing infection in occupied indoor public spaces. Our main method is accelerating commercialization and widespread adoption of 222nm FarUVC to sterilize the air and surfaces in public indoor spaces while people occupy them, as per Dr Brenner's vision. FarLight will launch soon. As of April 30 2020, we are 'in progress': a core team of technology and industry experts, developing the concept and establishing relationships with key partners. We welcome new collaborators and other inquiries. Contact Josh Whitkin josh@whitkin.com, or via linkedin.com/in/joshwhitkin.